Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2015 | Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer. | Liao, WY; Ho, CC; Hou, HH; Hsu, TH; Tsai, MF; Chen, KY; Chen, HY ; Lee, YC; Yu, CJ; Lee, CH; Yang, PC | The Journal of pathology 235(1), 50-64 | | | |
2008 | Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. | Gao, C; Ho, CC; Reineke, E; Lam, M; Cheng, X; Stanya, KJ; Liu, Y; Chakraborty, S; Shih, HM; Kao, HY | Molecular and cellular biology 28(18), 5658-67 | | | |
2015 | Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan. | Hsu, KH; Ho, CC; Hsia, TC; Tseng, JS; Su, KY; Wu, MF; Chiu, KL; Yang, TY; Chen, KC; Ooi, H; Wu, TC; Chen, HJ; Chen, HY ; Chang, CS; Hsu, CP; Hsia, JY; Chuang, CY; Lin, CH; Chen, JJ; Chen, KY; Liao, WY; Shih, JY; Yu, SL; Yu, CJ; Yang, PC; Chang, GC | PloS one 10(3), e0120852 | | | |
2016 | Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice | Su, KY; Kao, JT; Ho, BC; Chen, HY ; Chang, GC; Ho, CC; Yu, SL | Scientific reports 6, 30944 | | | |
2022 | Long-term exposure to ambient fine particulate matter (PM2.5) and associations with cardiopulmonary diseases and lung cancer in Taiwan: a nationwide longitudinal cohort study | Lo, WC; Ho, CC; Tseng, E; Hwang, JS ; Chan, CC; Lin, HH | International journal of epidemiology 51(4), 1230-1242 | | | |
2011 | Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. | Chang, CC; Naik, MT; Huang, YS; Jeng, JC; Liao, PH; Kuo, HY; Ho, CC; Hsieh, YL; Lin, CH; Huang, NJ; Naik, NM; Kung, CC; Lin, SY; Chen, RH; Chang, KS; Huang, TH; Shih, HM | Molecular cell 42(1), 62-74 | | | |
2011 | Structural and Functional Roles of Daxx SIM Phosphorylation in SUMO Paralogue-Selective Binding and Apoptosis Modulation. | Chang, CC; Naik, MT; Huang, YS; Jeng, JC; Liao, PH; Kuo, HY; Ho, CC; Hsieh, YL; Lin, CH; Huang, NJ; Naik, NM; Kung, CC; Lin, SY; Chen, RH; Chang, KS; Huang, TH; Shih, HM | Molecular cell 42(1), 62-74 | | | |
2009 | SUMO modification modulates the activity of calpain-2 | Wang, HC; Huang, YS; Ho, CC; Jeng, JC; Shih, H. -M. | Biochemical and Biophysical Research Communications 384(4), 444-449 | | | |
2018 | SUMOylation of XRCC1 activated by poly (ADP-ribosyl)ation regulates DNA repair. | Hu, LY; Chang, CC; Huang, YS; Chou, WC; Lin, YM; Ho, CC; Chen, WT; Shih, HM ; Hsiung, CN; Wu, PE; Shen, CY | Human molecular genetics 27(13), 2306-2317 | | | |
2020 | The M1/M2 Spectrum and Plasticity of Malignant Pleural Effusion-Macrophage in Advanced Lung Cancer | Wu, MF; Lin, CA; Yuan, TH; Yeh, HY; Su, SF; Guo, CL ; Chang, GC; Li, KC ; Ho, CC; Chen, HW | Cancer Immunology, Immunotherapy 70, 1435-1450 | | | |
2018 | The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis | Chang, CC; Huang, YS; Lin, YM; Lin, CJ; Jeng, JC; Liu, SM; Ho, TL; Chang, RT; Changou, C; Ho, CC; Shih, HM | Scientific Reports 8, 9786 | | | |
2008 | TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. | Ho, CC; Liao, WY; Wang, CY; Lu, YH; Huang, HY; Chen, HY ; Chan, WK; Chen, HW; Yang, PC | American journal of respiratory and critical care medicine 177(7), 763-770 | | | |
2012 | Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer | Yeh, CT; Wu, AT; Chang, PM; Chen, KY; Yang, CN; Yang, SC; Ho, CC; Chen, CC; Kuo, YL; Lee, PY; Liu, YW; Yen, CC; Hsiao, M; Lu, PJ; Lai, JM; Wang, LS; Wu, CH; Chiou, JF; Yang, PC; Huang, CY | Am J Respir Crit Care Med Dec 1;186(11):1180-8 | | | |
2009 | Tuning the conformational properties of the prion peptide. | Ho, CC; Lee, LY; Huang, KT; Lin, CC; Ku, MY; Yang, CC; Chan, SI; Hsu, RL; Chen, RP | PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS 76(1), 213-225 | | | |
2013 | Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response | Hsieh, YL; Kuo, HY; Chang, CC; Naik, MT; Liao, PH; Ho, CC; Huang, TC; Jeng, JC; Hsu, PH; Tsai, MD ; Huang, TH; Shih, HM | EMBO JOURNAL 32(6), 791-804 | | | |
2017 | YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas. | Lee, TF; Tseng, YC; Chang, WC; Chen, YC; Kao, YR; Chou, TY; Ho, CC; Wu, CW | Oncotarget 8(52), 89539-89551 | | | |